ClearPoint Neuro, Inc.
CLPT
$17.86
-$0.12-0.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.50% | 17.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.50% | 17.48% | |||
| Cost of Revenue | 9.14% | 22.85% | |||
| Gross Profit | 21.11% | 14.36% | |||
| SG&A Expenses | 39.23% | 13.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.63% | 10.74% | |||
| Operating Income | -61.64% | 0.59% | |||
| Income Before Tax | -22.64% | -32.28% | |||
| Income Tax Expenses | 100.00% | -50.00% | |||
| Earnings from Continuing Operations | -22.68% | -32.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.68% | -32.17% | |||
| EBIT | -61.64% | 0.59% | |||
| EBITDA | -66.13% | 5.43% | |||
| EPS Basic | -19.79% | -30.26% | |||
| Normalized Basic EPS | -55.79% | -0.23% | |||
| EPS Diluted | -19.79% | -30.26% | |||
| Normalized Diluted EPS | -55.79% | -0.23% | |||
| Average Basic Shares Outstanding | 2.42% | 1.48% | |||
| Average Diluted Shares Outstanding | 2.42% | 1.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||